Rebus Holdings, Inc. (RBSH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 11, 2025
Rebus Holdings Market Cap
Rebus Holdings has a market cap or net worth of $3.21 thousand as of July 25, 2025. Its market cap has decreased by -99.07% in one year.
Market Cap
3.21K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since November 2, 2009, Rebus Holdings's market cap has decreased from 30.37M to 3.21K, a decrease of -99.99%. That is a compound annual growth rate of -44.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 3.21K | 9,940.63% |
| Dec 31, 2024 | 32.00 | -99.98% |
| Dec 29, 2023 | 162.27K | -32.67% |
| Dec 30, 2022 | 241.00K | -12.12% |
| Dec 31, 2021 | 274.23K | -69.91% |
| Dec 31, 2020 | 911.25K | 1,469.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.35M |
| Glass House Brands | 435.78M |
| CytoDyn | 367.24M |
| Northwest Biotherapeutics | 367.14M |